Low-density lipoprotein cholesterol and risk of COPD: Copenhagen General Population Study

BACKGROUND: Randomised controlled trials found that low-density lipoprotein (LDL) cholesterol-lowering statins increase lung function and possibly decrease rate of exacerbations in individuals with COPD. However, it is unknown whether high levels of LDL cholesterol are associated with increased susc...

Descripción completa

Detalles Bibliográficos
Autores principales: Freyberg, Josefine, Landt, Eskild M., Afzal, Shoaib, Nordestgaard, Børge G., Dahl, Morten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986766/
https://www.ncbi.nlm.nih.gov/pubmed/36891075
http://dx.doi.org/10.1183/23120541.00496-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986766/
https://www.ncbi.nlm.nih.gov/pubmed/36891075
http://dx.doi.org/10.1183/23120541.00496-2022

Ejemplares similares